A carregar...
SWATH-proteomics of ibrutinib’s action in myeloid leukemia initiating mutated G-CSFR signaling
PURPOSE: To evaluate cellular protein changes in response to treatment with an approved drug, ibrutinib, in cells expressing normal or mutated Granulocyte-Colony Stimulating Factor Receptor (G-CSFR). G-CSFR mutations are associated with some hematological malignancies. Previous studies showed the ef...
Na minha lista:
| Publicado no: | Proteomics Clin Appl |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7492401/ https://ncbi.nlm.nih.gov/pubmed/32319217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prca.201900144 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|